Trials / Completed
CompletedNCT00166452
A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1
Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidamide in the Treatment of Complex Regional Pain Syndrome Type1
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if lenalidomide is a safe and effective treatment for complex regional pain syndrome type 1 (CRPS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lenalidamide |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2007-04-01
- Completion
- 2009-02-01
- First posted
- 2005-09-14
- Last updated
- 2011-03-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00166452. Inclusion in this directory is not an endorsement.